Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.

By Carmina E   Lobo R A  

Human Reproduction, Vol. 12, Iss. 4, 1997-04 ,pp. : 663-666

Oxford University Press

Access to resources Recommend Favorite

Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist/follicle stimulating hormone ovulation induction for in-vitro fertilization

By Lass A  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3203-3205

Oxford University Press

Access to resources Recommend Favorite

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite

Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.

By Fraser H M   Lunn S F   Morris K D   Deghenghi R  

Human Reproduction, Vol. 12, Iss. 3, 1997-03 ,pp. : 430-435

Oxford University Press

Access to resources Recommend Favorite

Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone

By Messinis IE  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2415-2420

Oxford University Press

Access to resources Recommend Favorite